CLINICAL_TRIALS trial_result · 2020-12-09

Clinical Trial Update: Study of Efficacy, Safety and Tolerability of AIN457 in Patients With Active Overuse Tendinopathy [Phase 2]

Phase 2 trial evaluating efficacy, safety, and tolerability of AIN457 in active overuse tendinopathy has completed; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Novartis Pharmaceuticals | Conditions: Tendinopathy | Phase 2 | Status: COMPLETED | Results posted: 2020-12-09